US Bancorp
CLOV icon

US Bancorp’s Clover Health Investments CLOV Stock Holding History

US Bancorp’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749 Sell
143
-1,750
-92% -$5.94K ﹤0.01% 4013
2026
Q1 		$3.33K Buy
1,893
+1,811
+2,209% +$3.93K ﹤0.01% 3685
2025
Q4 		$193 Hold
82
– – ﹤0.01% 3975
2025
Q3 		$251 Buy
+82
New +$234 ﹤0.01% 3923
2025
Q2 		– Sell
-542
Closed -$1.95K – 4185
2025
Q1 		$1.95K Sell
542
-321
-37% -$1.29K ﹤0.01% 3886
2024
Q4 		$2.72K Buy
863
+813
+1,626% +$2.9K ﹤0.01% 3800
2024
Q3 		$141 Buy
+50
New +$114 ﹤0.01% 4028
2023
Q2 		– Sell
-5,682
Closed -$4.8K – 4014
2023
Q1 		$4.8K Sell
5,682
-526
-8% -$576 ﹤0.01% 3532
2022
Q4 		$5.77K Sell
6,208
-2,913
-32% -$3.89K ﹤0.01% 3466
2022
Q3 		$16K Hold
9,121
– – ﹤0.01% 3140
2022
Q2 		$20K Hold
9,121
– – ﹤0.01% 3038
2022
Q1 		$32K Hold
9,121
– – ﹤0.01% 2830
2021
Q4 		$34K Hold
9,121
– – ﹤0.01% 2837
2021
Q3 		$67K Buy
+9,121
New +$78K ﹤0.01% 2498

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

US Bancorp's CLOV Position: Q2 2026 in Review

US Bancorp reduced its Clover Health Investments (CLOV) stake by 92% in Q2 2026, selling an estimated $5.94K and leaving 143 shares worth $749. The position accounts for ﹤0.01% of the portfolio, ranked #4013.

US Bancorp first reported a position in CLOV in Q3 2021 and has held it in 14 quarters since. The position peaked at $67K in Q3 2021. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • US Bancorp held 143 shares of Clover Health Investments worth $749 as of Q2 2026.
  • US Bancorp sold 1,750 Clover Health Investments shares in Q2 2026, an estimated $5.94K.
  • Clover Health Investments made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4013 holding.
  • US Bancorp first reported a position in Clover Health Investments in Q3 2021 and has held it in 14 quarters since.
  • US Bancorp's Clover Health Investments position peaked at $67K in Q3 2021.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.